MedPath

The effect of Single tablet of fixed dose Mitiglinide and Voglibose or Linagliptine with Insulin Degludec.

Not Applicable
Conditions
Type 2 Diabetes
Registration Number
JPRN-UMIN000013689
Lead Sponsor
ational Center for Global Health and Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with severe renal dysfunction, severe liver dysfunction, type 1diabetes, glutamic acid decarboxylase antibody positivity, malignancy, or other causes of hyperglycemia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Area Under the Curve of postprandial glucose levels after taking a test meal.
Secondary Outcome Measures
NameTimeMethod
The Area Under the Curve of postprandial glucose levels after taking a low carbohydrate diet. HbA1c, GA, and 1,5-AG.
© Copyright 2025. All Rights Reserved by MedPath